{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["COVID-19", "Coronavirus", "Ozone", "Pandemic", "SARS-CoV-2"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32838159", "DateRevised": {"Year": "2022", "Month": "02", "Day": "18"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "07", "Day": "07"}], "ELocationID": ["10.1007/s42399-020-00328-7"], "Journal": {"ISSN": "2523-8973", "JournalIssue": {"Volume": "2", "Issue": "8", "PubDate": {"Year": "2020"}}, "Title": "SN comprehensive clinical medicine", "ISOAbbreviation": "SN Compr Clin Med"}, "ArticleTitle": "Ozone (O3) and SARS-CoV-2: Physiological Bases and Their Therapeutic Possibilities According to COVID-19 Evolutionary Stage.", "Pagination": {"StartPage": "1094", "EndPage": "1102", "MedlinePgn": "1094-1102"}, "Abstract": {"AbstractText": ["To date, there is no definitive treatment for the new SARS-CoV-2 pandemic. Three evolutionary stages in SARS-CoV-2 infection are recognized (early infection, pulmonary phase, and systemic hyper inflammation), with characteristic clinical signs and symptoms. There are 80 international experimental trials underway seeking effective treatment for the COVID-19 pandemic. Of these, there are only three that consider ozone therapy (major auto hemotherapy) as an alternative option. There is no study that evaluates rectal ozone insufflation, despite being a safe, cheap, risk-free technique. That technique is a systemic route of ozone administration (95-96%) and that could be extrapolated to the use of SARS-CoV-2, given the excellent results observed in the management of Ebola. Ozone has four proven biological properties that could allow its use as an alternative therapy in the different phases of SARS-CoV-2 infection. Ozone could inactivate the virus by direct (O3) or indirect oxidation (ROS and LOPs) and could stimulate the cellular and humoral immune systems, being useful in the early COVID-19 infection phase (stages 1 and 2a). Ozone improves gas exchange, reduces inflammation, and modulates the antioxidant system, so it would be useful in the hyper inflammation or \"cytokine storm\" phase, and in the hypoxemia and/or multi-organ failure phase (stage 2b and stage 3). Given the current pandemic, it is urgent to carry out an experimental study that confirms or rules out the biological properties of ozone and thus allows it to be an alternative or compassionate therapy for the effective management of SARS-Cov-2 infection. The Ethical Committee at our Hospital has authorized the use of this technique for compassionate management of SARS-CoV-2 infection, considering the four biological Ozone properties exposed previously."], "CopyrightInformation": "\u00a9 Springer Nature Switzerland AG 2020."}, "AuthorList": [{"Identifier": ["0000-0001-6153-9075"], "AffiliationInfo": [{"Identifier": ["grid.411359.b", "0000 0004 1763 1052"], "Affiliation": "Calle del Maestro Vives 2 y 3, Servicio de Medicina F\u00edsica y Rehabilitaci\u00f3n, Hospital Universitario Santa Cristina, CP28009 Madrid, Spain."}], "LastName": "Fern\u00e1ndez-Cuadros", "ForeName": "Marcos Edgar", "Initials": "ME"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411359.b", "0000 0004 1763 1052"], "Affiliation": "Calle del Maestro Vives 2 y 3, Servicio de Medicina F\u00edsica y Rehabilitaci\u00f3n, Hospital Universitario Santa Cristina, CP28009 Madrid, Spain."}], "LastName": "Albaladejo-Flor\u00edn", "ForeName": "Mar\u00eda Jes\u00fas", "Initials": "MJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411359.b", "0000 0004 1763 1052"], "Affiliation": "Unidad de Geriatr\u00eda, Hospital Universitario Santa Cristina, Madrid, Spain."}], "LastName": "Pe\u00f1a-Lora", "ForeName": "Daiana", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411359.b", "0000 0004 1763 1052"], "Affiliation": "Calle del Maestro Vives 2 y 3, Servicio de Medicina F\u00edsica y Rehabilitaci\u00f3n, Hospital Universitario Santa Cristina, CP28009 Madrid, Spain."}], "LastName": "\u00c1lava-Rabasa", "ForeName": "Sandra", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411359.b", "0000 0004 1763 1052"], "Affiliation": "Calle del Maestro Vives 2 y 3, Servicio de Medicina F\u00edsica y Rehabilitaci\u00f3n, Hospital Universitario Santa Cristina, CP28009 Madrid, Spain."}], "LastName": "P\u00e9rez-Moro", "ForeName": "Olga Susana", "Initials": "OS"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "SN Compr Clin Med", "NlmUniqueID": "101740833", "ISSNLinking": "2523-8973"}, "CoiStatement": "The authors note that there is no commercial relationship giving rise to a conflict of interest in conducting this study.Conflict of InterestThe authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2018;23(2):130\u2013137. doi: 10.1111/resp.13196.", "ArticleIdList": ["10.1111/resp.13196", "PMC7169239", "29052924"]}, {"Citation": "Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, Neuman BW. Severe acute respiratory syndrome-related coronavirus: the species and its viruses: a statement of the Coronavirus Study Group. bioRxiv. 2020;10(2020.02):07\u2013937862."}, {"Citation": "Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Yu T. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u2013513. doi: 10.1016/S0140-6736(20)30211-7.", "ArticleIdList": ["10.1016/S0140-6736(20)30211-7", "PMC7135076", "32007143"]}, {"Citation": "WHO Coronavirus disease (COVID-2019) situation reports. 2020."}, {"Citation": "Hung LS. The SARS epidemic in Hong Kong: what lessons have we learned? J R Soc Med. 2003;96(8):374\u2013378. doi: 10.1177/014107680309600803.", "ArticleIdList": ["10.1177/014107680309600803", "PMC539564", "12893851"]}, {"Citation": "Chen N, Zhou M, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020. 395:507-13. 10.1016/S0140-6736(20)30211-7.", "ArticleIdList": ["PMC7135076", "32007143"]}, {"Citation": "Li H, Zhou Y, Zhang M, Zhao Q, Liu J. Updated approaches against SARS-CoV-2. Antimicrob Agents Chemother. 2020.", "ArticleIdList": ["PMC7269512", "32205349"]}, {"Citation": "Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395(10223):473\u2013475. doi: 10.1016/S0140-6736(20)30317-2.", "ArticleIdList": ["10.1016/S0140-6736(20)30317-2", "PMC7134694", "32043983"]}, {"Citation": "Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269\u2013271. doi: 10.1038/s41422-020-0282-0.", "ArticleIdList": ["10.1038/s41422-020-0282-0", "PMC7054408", "32020029"]}, {"Citation": "Lim, J., Jeon, S., Shin, H. Y., Kim, M. J., Seong, Y. M., Lee, W. J., . & Park, S. J. (2020). Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J Korean Med Sci, 35(6).", "ArticleIdList": ["PMC7025910", "32056407"]}, {"Citation": "Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, Nichol ST. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2(1):69. doi: 10.1186/1743-422X-2-69.", "ArticleIdList": ["10.1186/1743-422X-2-69", "PMC1232869", "16115318"]}, {"Citation": "Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020:105938.", "ArticleIdList": ["PMC7118659", "32171740"]}, {"Citation": "Gautret, P., Lagier, J. C., Parola, P., Meddeb, L., Mailhe, M., Doudier, B., . & Honor\u00e9, S. (2020). Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents, 105949.", "ArticleIdList": ["PMC7102549", "32205204"]}, {"Citation": "Carrillo B, Mart\u00ednez E. COVID-19 y Acupuntura: \u00bfexiste una nueva l\u00ednea de investigaci\u00f3n terap\u00e9utica? Revista Digital de Acupuntura. N\u00famero Extraordinario Marzo. 2020;3(1):1\u201321."}, {"Citation": "Fernandez-Cuadros ME, Perez-Moro OS, Albaladejo-Florin MJ. Ozone fundamentals and effectiveness in knee pain: chondromalacia and knee osteoarthritis. Saarbr\u00fccken: Lambert Academic Publishing; 2016."}, {"Citation": "Fern\u00e1ndez-Cuadros Marcos Edgar, P\u00e9rez-Moro Olga Susana, Albaladejo-Florin Mar\u00eda Jes\u00fas, Alava-Rabasa Sandra. El ozono intraarticular modula la inflamaci\u00f3n, mejora el dolor, la rigidez, la funci\u00f3n y tiene un efecto anab\u00f3lico sobre la artrosis de rodilla: estudio cuasi-experimental prospectivo tipo antes-despu\u00e9s, 115 pacientes. Intra-articular Ozone modulates inflammation, ameliorates pain and rigidity, improves function and has anabolic effect on knee osteoarthritis: a prospective quasiexperimental before-and-after study, 115 patients. Rev Soc Esp Dolor 2020. doi: 10.20986/resed.2020.3775/2019."}, {"Citation": "Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, Bucci E, Piacentini M, Ippolito G, Melino G. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27:1451\u20131454. doi: 10.1038/s41418-020-0530-3.", "ArticleIdList": ["10.1038/s41418-020-0530-3", "PMC7091918", "32205856"]}, {"Citation": "Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y., Tian DS Dysregulation of immune response in patients with COVID-19 in Wuhan, China. 2020 China (February 17, 2020).", "ArticleIdList": ["PMC7108125", "32161940"]}, {"Citation": "Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506. doi: 10.1016/S0140-6736(20)30183-5.", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "Karakike E, Giamarellos-Bourboulis EJ. Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis. Front Immunol. 2019;10.", "ArticleIdList": ["PMC6365431", "30766533"]}, {"Citation": "Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intens Care Med. 2020:1-3.", "ArticleIdList": ["PMC7080116", "32125452"]}, {"Citation": "Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Guan L. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054\u20131062. doi: 10.1016/S0140-6736(20)30566-3.", "ArticleIdList": ["10.1016/S0140-6736(20)30566-3", "PMC7270627", "32171076"]}, {"Citation": "Shimabukuro-Vornhagen A, G\u00f6del P, Subklewe M, Stemmler HJ, Schl\u00f6\u00dfer HA, Schlaak M, Kochanek M, B\u00f6ll B, von Bergwelt-Baildon MS. Cytokine release syndrome. J Immunother Cancer. 2018;6(1):56. doi: 10.1186/s40425-018-0343-9.", "ArticleIdList": ["10.1186/s40425-018-0343-9", "PMC6003181", "29907163"]}, {"Citation": "Mehta P, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020. 10.1016/S0140-6736(20)30630-9.", "ArticleIdList": ["PMC7270045", "32192578"]}, {"Citation": "Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical- therapeutic staging proposal. J Heart Lung Transplant. 2020;39:405\u2013407. doi: 10.1016/j.healun.2020.03.012.", "ArticleIdList": ["10.1016/j.healun.2020.03.012", "PMC7118652", "32362390"]}, {"Citation": "Bocci V. Ozone: a new medical drug. 2. Dordrecht: Springer Verlag; 2011."}, {"Citation": "Iliakis E, Valadakis V, Vynios DH, Tsiganos CP, Agapitos E. Rationalization of the activity of medical ozone on intervertebral disc a histological and biochemical study. Riv Neuroradiol. 2001;14(1 suppl):23\u201330. doi: 10.1177/19714009010140S105.", "ArticleIdList": ["10.1177/19714009010140S105"]}, {"Citation": "Paoloni M, Di Sante L, Cacchio A, Apuzzo D, Marotta S, et al. Intramuscular oxygen-ozone therapy in the treatment of acute back pain with lumbar disc herniation: a multicenter, randomized, double-blind, clinical trial of active and simulated lumbar paravertebral injection. Spine. 2009;4(13):1337\u20131344. doi: 10.1097/BRS.0b013e3181a3c18d.", "ArticleIdList": ["10.1097/BRS.0b013e3181a3c18d", "19478653"]}, {"Citation": "Seyman D, Ozen NS, Inan D, Ongut G, Ogunc D. Pseudomona aeruginosa septic arthritis of knee after intra-articular ozone injection. New Microbiol. 2012;35(3):345\u2013348.", "ArticleIdList": ["22842605"]}, {"Citation": "Mawsouf N, El-Sawalhi MM, Shaheen AA, Darwish HA, Martinez-Sanchez, et al. Effect of ozone therapy on redox status in experimentally induced arthritis. Rev Esp Ozonoterapia. 2011;1(1):32\u201343."}, {"Citation": "Madrigal C. Tratado de Ozonoterapia. Madrid: Editorial la Salud Naturalmente; 2007."}, {"Citation": "Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 2006;37(4):425\u2013435. doi: 10.1016/j.arcmed.2005.08.006.", "ArticleIdList": ["10.1016/j.arcmed.2005.08.006", "16624639"]}, {"Citation": "Babior BM, Takeuchi C, Ruedi J, Gutierrez A, Wentworth P. Investigating antibody-catalyzed ozone generation by human neutrophils. Proc Natl Acad Sci. 2003;100(6):3031\u20133034. doi: 10.1073/pnas.0530251100.", "ArticleIdList": ["10.1073/pnas.0530251100", "PMC152239", "12601145"]}, {"Citation": "Rowen RJ, Robins H. A plausible \u201cpenny\u201d costing effective treatment for corona virus ozone therapy. J Infect Dis Epidemiol. 2020;6:113."}, {"Citation": "Eren E, Saribek F, Kayalayci, Yilmaz N. How to cripple SARS-COV-2 virus with Ozone treatment thiol groups in viruses and SARS-COV-2, Traditional and Complementary Medicine, 2020."}, {"Citation": "Schoeman D, Fielding BC. Coronavirus envelope protein: current knowledge. Virol J. 2019;16:69. doi: 10.1186/s12985-019-1182-0.", "ArticleIdList": ["10.1186/s12985-019-1182-0", "PMC6537279", "31133031"]}, {"Citation": "Madu IG, Belouzard S, Whittaker GR. SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion. Virology. 2009;393:265\u2013271. doi: 10.1016/j.virol.2009.07.038.", "ArticleIdList": ["10.1016/j.virol.2009.07.038", "PMC3594805", "19717178"]}, {"Citation": "Sharma VK, Graham NJ. Oxidation of amino acids, peptides and proteins by ozone: a review. Ozone Sci Eng. 2010;32(2):81\u201390. doi: 10.1080/01919510903510507.", "ArticleIdList": ["10.1080/01919510903510507"]}, {"Citation": "Reth M. Hydrogen peroxide as second messenger in lymphocyteactivation. Nat Immunol. 2002;3:1129\u20131134. doi: 10.1038/ni1202-1129.", "ArticleIdList": ["10.1038/ni1202-1129", "12447370"]}, {"Citation": "Martinez-Sanchez G. Mechanisms of action of O3. Genomic pathways. Ozone Ther Glob J. 2019;9(1):21\u201322."}, {"Citation": "Delgado-Roche L, Riera-Romo M, Mesta F, Hern\u00e1ndez-Matos Y, Barrios JM, Mart\u00ednez-S\u00e1nchez G. Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and proinflammatory cytokines in multiple sclerosis patients. Rev Esp Ozonoterapia. 2018;8(2 Supp 1):48\u201349.", "ArticleIdList": ["28623000"]}, {"Citation": "Martinez-Sanchez G, Delgado-Roche L. Up-date on the mechanisms of action of ozone through the modification of cellular signaling pathways. Role of Nrf2 and NFkb. Rev Esp Ozonoterapia. 2017;7(2):17\u201318."}, {"Citation": "Bocci V, Valacchi G. Nrf2 activation as target to implement therapeutic treatments. Front Chem. 2015;3:4. doi: 10.3389/fchem.2015.00004.", "ArticleIdList": ["10.3389/fchem.2015.00004", "PMC4313773", "25699252"]}, {"Citation": "Re L, Martinez-Sanchez G, Bordicchia M, et al. Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result. Eur J Pharmacol. 2014;742:158\u2013162. doi: 10.1016/j.ejphar.2014.08.029.", "ArticleIdList": ["10.1016/j.ejphar.2014.08.029", "25218903"]}, {"Citation": "Fernandez-Cuadros ME, Perez-Moro OS, Mir\u00f3n-Canelo JA. Could ozone be used as a feasible future treatment in osteoarthritis of the knee. Divers Equal Health Care. 2016;13(3):232\u2013239."}, {"Citation": "Fern\u00e1ndez-Cuadros ME, P\u00e9rez-Moro OS, Albaladejo-Flor\u00edn MJ, \u00c1lava-Rabasa S, Tobar-Izquierdo M, Rodriguez-de-C\u00eda J. Sci Rep. 2020;2(1) [In press]."}, {"Citation": "Schwartz A, Martinez-S\u00e1nchez G. Uso potencial complementario y compasivo de la ozonoterapia sistemica en el COVI-19. AEPROMO, 2020, In Press."}, {"Citation": "Rowen RJ. Ozone and oxidation therapies as a solution to the emerging crisis in infectious disease management: a review of current knowledge and experience. Med Gas Res. 2019;9(4):232.", "ArticleIdList": ["PMC7802416", "31898609"]}, {"Citation": "Schwartz A, Sanchez GM, Sabah F Declaraci\u00f3n de Madrid sobre la ozonoterapia. 2a edi\u00e7\u00e3o. 2015"}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "5", "Day": "19"}, {"Year": "2020", "Month": "8", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "25", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "8", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "8"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32838159", "PMC7340747", "10.1007/s42399-020-00328-7", "328"]}}], "PubmedBookArticle": []}